Searched for
BIOCON BRAZIL PARTNERSHIP
Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealActive Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...
- Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- 'Brazil an important, strategic partner to India; key member of BRICS,' MEA Secy (East) saysIndia and Brazil strengthened their strategic partnership during President Luiz Inacio Lula da Silva's state visit. Discussions covered bil...
- Biocon Q2 Results: Profit soars 428% YoY to Rs 85 crore on strong biosimilar and generics growthBiocon Group reported a strong Q2 FY26 with a 20% year-on-year increase in operating revenue to Rs 4,296 crore, driven by biosimilars and g...
- Biocon plans to launch generic Wegovy obesity drug in India by 2027, CEO saysBiocon is set to launch generic versions of Wegovy in India and Canada, aiming for market entry by late 2026 or early 2027. This strategic ...
- Biocon partners Biomm to commercialise diabetes drug in BrazilBiocon has partnered with Brazil-based Biomm SA for the commercialization of its diabetes drug, Semaglutide (gOzempic). Biocon will develop...
- Biocon rises 3% as co enters Brazilian generic formulation marketChief Executive Officer and Managing Director, Siddharth Mittal, Biocon Ltd, said the association with Libbs Farmaceutica will help his com...
- Biocon partners with Libbs Farmaceutica to launch generic drugs in BrazilThis partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libb...
- Mylan-Biocon's breast cancer biosimilar gets ANVISA nodBiosimilar trastuzumab, indicated for breast cancer treatment, has been co-developed by Biocon and Mylan.
- New Companies Act: Technical issues force many firms to seek for limited liability partnership structuresThe new Companies Act, which came in to effect on April 1, demands much more information as well as disclosures, making the entire process ...
- Biocon looking at new global partnerships for its biosimilarsBiocon is now exploring new partnerships with pharma companies for its biosimilars, or low-cost copies of biotechnology products.
- Biocon seeks marketing alliances in several emerging marketsBangalore-based Biocon is planning to forge partnerships as well as leverage existing alliances to augment the access and penetration of it...
Load More
